Basal Insulin Case 2

CE / CME

The Role of Basal Insulin in the Modern Era of Diabetes Management: Interactive Case Challenge 2

ABIM MOC: maximum of 0.75 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 0.75 AAPA Category 1 CME credit

Nurses: 0.75 Nursing contact hour

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Released: October 26, 2023

Expiration: October 25, 2024

Steven V. Edelman
Steven V. Edelman, MD

Activity

Progress
1
Course Completed

Follow-up—Case Continued
The patient continues to titrate degludec per instructions to reach an FBG target of <130 mg/dL. At her 1-month follow-up, the patient reports taking degludec 32 units at bedtime in addition to her other medications. Her AGP shows a TIR of 60%, a TAR of 36, and a TBR of 4%. Her FBG average has decreased to 145 mg/dL. She reports that her hypoglycemic symptoms have mostly resolved, with occasional low blood glucose readings due to missed meals during the day. 

Question 2

Which of the following additional interventions would be best for this patient at this time to improve blood glucose control?